These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20034464)

  • 21. The J6JFH1 strain of hepatitis C virus infects human B-cells with low replication efficacy.
    Nakai M; Seya T; Matsumoto M; Shimotohno K; Sakamoto N; Aly HH
    Viral Immunol; 2014 Aug; 27(6):285-94. PubMed ID: 24853207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients.
    Lau DT; Fish PM; Sinha M; Owen DM; Lemon SM; Gale M
    Hepatology; 2008 Mar; 47(3):799-809. PubMed ID: 18203148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
    Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
    J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential association of hepatitis C virus with CD19
    Wang RY; Bare P; De Giorgi V; Matsuura K; Salam KA; Grandinetti T; Schechterly C; Alter HJ
    Hepatology; 2016 Dec; 64(6):1900-1910. PubMed ID: 27641977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.
    Libra M; Capello D; Gloghini A; Laura P; Berra E; Cerri M; Gasparotto D; Franca S; De Re V; Gaidano G; Carbone A
    J Pathol; 2005 May; 206(1):87-91. PubMed ID: 15809970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection.
    Atencia R; Bustamante FJ; Valdivieso A; Arrieta A; Riñón M; Prada A; Maruri N
    BMC Infect Dis; 2007 Nov; 7():136. PubMed ID: 18021446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
    Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
    J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.
    Foy E; Li K; Sumpter R; Loo YM; Johnson CL; Wang C; Fish PM; Yoneyama M; Fujita T; Lemon SM; Gale M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2986-91. PubMed ID: 15710892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes.
    Tucci FA; Broering R; Johansson P; Schlaak JF; Küppers R
    J Virol; 2013 Mar; 87(5):2956-62. PubMed ID: 23269799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
    Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
    Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins.
    Strähle L; Marq JB; Brini A; Hausmann S; Kolakofsky D; Garcin D
    J Virol; 2007 Nov; 81(22):12227-37. PubMed ID: 17804509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
    Hassan M; Selimovic D; Ghozlan H; Abdel-Kader O
    Cell Signal; 2007 Feb; 19(2):301-11. PubMed ID: 16916598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
    Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
    Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins.
    Machida K; Tsukiyama-Kohara K; Sekiguch S; Seike E; Tóne S; Hayashi Y; Tobita Y; Kasama Y; Shimizu M; Takahashi H; Taya C; Yonekawa H; Tanaka N; Kohara M
    Gastroenterology; 2009 Jul; 137(1):285-96, 296.e1-11. PubMed ID: 19362089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular signature in HCV-positive lymphomas.
    De Re V; Caggiari L; Garziera M; De Zorzi M; Repetto O
    Clin Dev Immunol; 2012; 2012():623465. PubMed ID: 22952554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I.
    Feigelstock DA; Mihalik KB; Kaplan G; Feinstone SM
    Virol J; 2010 Feb; 7():44. PubMed ID: 20170495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.